Insider Trading activities at Amicus Therapeutics, Inc. (FOLD) , Part 2

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Amicus Therapeutics, Inc. (FOLD) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Amicus Therapeutics, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1178879.

Total stock buying since 2015: $43,277,398.
Total stock sales since 2015: $100,659,546.
Total stock option exercises since 2015: $44,003,589.


 1   2   3   4 
27 insiders reported insider trading activities at Amicus Therapeutics, Inc. (FOLD):
Insider trading activities of Hayden Donald J Jr
Insider trading activities of Bleil Lynn Dorsey
Insider trading activities of Barth Jay
Insider trading activities of Castelli Jeff
Insider trading activities of Doshi Dipal
Insider trading activities of Valenzano Ken
Insider trading activities of Quimi Daphne
Insider trading activities of Kirk John
Insider trading activities of Perceptive Life Sciences Master Fund Ltd
Insider trading activities of Mcglynn Margaret G
Insider trading activities of Rosenberg Ellen
Insider trading activities of Gershkowitz Jayne
Insider trading activities of Crowley John F
Insider trading activities of Campbell Bradley L
Insider trading activities of Whitman Burke W
Insider trading activities of Dilone Enrique
Insider trading activities of Peist Kenneth
Insider trading activities of Do Hung
Insider trading activities of Raab Michael
Insider trading activities of Yu Julie
Insider trading activities of Baird William D Iii
Insider trading activities of Prout Samantha
Insider trading activities of Andrews Kurt J.
Insider trading activities of Clark David Michael
Insider trading activities of Sblendorio Glenn
Insider trading activities of Green Jeremy
Insider trading activities of Edelman Joseph

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Amicus Therapeutics, Inc. (FOLD).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 252,639 $2,531,515 175,195 $1,226,545
2024 0 $0 399,658 $5,124,634 182,067 $1,360,541
2023 0 $0 813,767 $10,307,679 457,240 $2,081,221
2022 0 $0 424,370 $4,449,738 116,155 $466,726
2021 45,105 $451,689 557,791 $7,173,882 411,757 $2,127,182
2020 11,000 $175,512 1,681,390 $24,511,559 1,284,060 $8,873,723
2019 4,945 $49,796 572,269 $6,783,107 547,724 $2,955,368
2018 1,235,827 $15,744,014 301,765 $4,590,161 201,765 $1,644,814
2017 1,501,395 $18,395,032 971,072 $12,606,562 913,823 $11,449,856
2016 592,950 $3,020,945 1,260,420 $8,649,277 156,358 $50,864
2015 810,000 $5,440,410 1,080,786 $13,931,432 1,273,641 $11,766,749


Table 3. Detailed insider trading at Amicus Therapeutics, Inc. (FOLD) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2022-07-01 Campbell Bradley L (Chief Operating Officer) Sale 5,470 10.72 58,616
2022-07-01 Campbell Bradley L (Chief Operating Officer) Option Ex 5,470 3.53 19,309
2022-06-21 Rosenberg Ellen (Chief Legal Officer) Sale 11,122 10.01 111,275
2022-06-21 Campbell Bradley L (Chief Operating Officer) Sale 16,410 10.00 164,100
2022-06-21 Campbell Bradley L (Chief Operating Officer) Option Ex 16,410 3.53 57,927
2022-06-17 Quimi Daphne (Chief Financial Officer) Sale 4,396 9.00 39,564
2022-06-15 Crowley John F (Chairman & CEO) Sale 10,468 8.01 83,838
2022-06-03 Crowley John F (Chairman & CEO) Sale 11,346 8.00 90,768
2022-05-23 Crowley John F (Chairman & CEO) Sale 21,814 8.00 174,577
2022-05-02 Raab Michael (Director) Sale 15,000 6.99 104,895
2022-05-02 Raab Michael (Director) Option Ex 15,000 4.79 71,850
2022-05-02 Mcglynn Margaret G (Director) Sale 15,000 6.99 104,895
2022-05-02 Mcglynn Margaret G (Director) Option Ex 15,000 4.79 71,850
2022-04-19 Crowley John F (Chairman & CEO) Sale 8,254 8.01 66,081
2022-04-18 Crowley John F (Chairman & CEO) Sale 2,214 8.04 17,793
2022-04-07 Rosenberg Ellen (Chief Legal Officer) Sale 11,018 9.06 99,801
2022-03-18 Campbell Bradley L (Chief Operating Officer) Sale 10,940 10.00 109,421
2022-03-18 Campbell Bradley L (Chief Operating Officer) Option Ex 10,940 3.53 38,618
2022-03-04 Sblendorio Glenn (Director) Option Ex 15,000 4.79 71,850
2022-01-18 Crowley John F (Chairman & CEO) Sale 8,564 10.23 87,609
2022-01-05 Crowley John F (Chairman & CEO) Sale 63,543 12.18 774,144
2022-01-03 Campbell Bradley L (Chief Operating Officer) Sale 5,470 11.86 64,879
2022-01-03 Campbell Bradley L (Chief Operating Officer) Option Ex 5,470 3.53 19,309
2021-12-22 Campbell Bradley L (Chief Operating Officer) Sale 3,000 11.70 35,097
2021-12-22 Campbell Bradley L (Chief Operating Officer) Option Ex 3,000 4.38 13,140
2021-12-01 Campbell Bradley L (Chief Operating Officer) Sale 10,515 11.00 115,707
2021-12-01 Campbell Bradley L (Chief Operating Officer) Option Ex 10,515 4.38 46,055
2021-11-15 Crowley John F (Chairman & CEO) Sale 24,935 11.75 292,961
2021-11-15 Crowley John F (Chairman & CEO) Option Ex 24,935 4.38 109,215
2021-11-03 Crowley John F (Chairman & CEO) Sale 27,739 12.00 332,868
2021-11-03 Crowley John F (Chairman & CEO) Option Ex 27,739 3.82 105,962
2021-11-01 Crowley John F (Chairman & CEO) Sale 7,819 10.80 84,453
2021-11-01 Campbell Bradley L (Chief Operating Officer) Sale 10,515 11.32 119,050
2021-11-01 Campbell Bradley L (Chief Operating Officer) Option Ex 10,515 4.38 46,055
2021-11-01 Whitman Burke W (Director) Buy 1,500 10.49 15,735
2021-10-15 Crowley John F (Chairman & CEO) Sale 22,000 11.22 246,862
2021-10-15 Crowley John F (Chairman & CEO) Option Ex 22,000 4.38 96,360
2021-10-01 Crowley John F (Chairman & CEO) Sale 7,500 10.00 75,000
2021-10-01 Campbell Bradley L (Chief Operating Officer) Sale 10,515 10.00 105,150
2021-10-01 Campbell Bradley L (Chief Operating Officer) Option Ex 10,515 4.38 46,055
2021-10-01 Whitman Burke W (Director) Buy 1,500 9.56 14,346
2021-09-15 Crowley John F (Chairman & CEO) Sale 22,000 11.08 243,826
2021-09-15 Crowley John F (Chairman & CEO) Option Ex 22,000 4.38 96,360
2021-09-03 Prout Samantha (Principal Accounting Officer) Sale 4,925 12.01 59,168
2021-09-03 Prout Samantha (Principal Accounting Officer) Option Ex 4,925 9.79 48,240
2021-09-03 Crowley John F (Chairman & CEO) Sale 5,238 12.02 62,945
2021-09-03 Crowley John F (Chairman & CEO) Option Ex 5,238 3.67 19,249
2021-09-01 Crowley John F (Chairman & CEO) Sale 7,500 11.50 86,250
2021-09-01 Campbell Bradley L (Chief Operating Officer) Sale 10,515 11.50 120,901
2021-09-01 Campbell Bradley L (Chief Operating Officer) Option Ex 10,515 4.38 46,055
2021-09-01 Whitman Burke W (Director) Buy 1,500 11.41 17,115
2021-08-23 Prout Samantha (Principal Accounting Officer) Sale 5,045 11.00 55,495
2021-08-16 Crowley John F (Chairman & CEO) Sale 22,000 10.27 225,918
2021-08-16 Crowley John F (Chairman & CEO) Option Ex 22,000 4.38 96,360
2021-08-05 Crowley John F (Chairman & CEO) Sale 37,000 10.03 371,036
2021-08-05 Crowley John F (Chairman & CEO) Option Ex 22,000 4.38 96,360
2021-08-05 Campbell Bradley L (Chief Operating Officer) Sale 21,028 10.02 210,679
2021-08-05 Campbell Bradley L (Chief Operating Officer) Option Ex 21,028 4.38 92,102
2021-08-02 Whitman Burke W (Director) Buy 1,500 9.28 13,919
2021-07-12 Crowley John F (Chairman & CEO) Sale 14,885 9.31 138,653
2021-07-01 Whitman Burke W (Director) Buy 1,500 9.60 14,400
2021-06-15 Crowley John F (Chairman & CEO) Sale 22,000 10.26 225,632
2021-06-15 Crowley John F (Chairman & CEO) Option Ex 22,000 4.38 96,360
2021-06-01 Whitman Burke W (Director) Buy 1,500 9.24 13,861
2021-05-25 Bleil Lynn Dorsey (Director) Buy 28,605 8.74 250,007
2021-05-18 Raab Michael (Director) Option Ex 5,634 7.56 42,593
2021-05-03 Crowley John F (Chairman & CEO) Sale 7,500 10.28 77,092
2021-05-03 Campbell Bradley L (Chief Operating Officer) Sale 10,514 10.27 107,968
2021-05-03 Campbell Bradley L (Chief Operating Officer) Option Ex 10,514 6.45 67,815
2021-05-03 Mcglynn Margaret G (Director) Sale 10,000 10.27 102,700
2021-05-03 Mcglynn Margaret G (Director) Option Ex 10,000 7.51 75,100
2021-05-03 Whitman Burke W (Director) Buy 1,500 10.21 15,315
2021-04-22 Crowley John F (Chairman & CEO) Sale 7,683 10.01 76,899
2021-04-15 Crowley John F (Chairman & CEO) Sale 22,000 10.10 222,090
2021-04-15 Crowley John F (Chairman & CEO) Option Ex 22,000 6.45 141,900
2021-04-01 Crowley John F (Chairman & CEO) Sale 7,500 10.00 75,000
2021-04-01 Campbell Bradley L (Chief Operating Officer) Sale 10,514 10.04 105,507
2021-04-01 Campbell Bradley L (Chief Operating Officer) Option Ex 10,514 6.45 67,815
2021-04-01 Whitman Burke W (Director) Buy 1,500 10.00 15,000
2021-03-22 Crowley John F (Chairman & CEO) Sale 7,682 10.29 79,063
2021-03-15 Crowley John F (Chairman & CEO) Sale 22,000 10.77 236,984
2021-03-15 Crowley John F (Chairman & CEO) Option Ex 22,000 6.45 141,900
2021-03-05 Quimi Daphne (Chief Financial Officer) Option Ex 16,628 2.94 48,886
2021-03-01 Crowley John F (Chairman & CEO) Sale 7,500 11.85 88,882
2021-03-01 Campbell Bradley L (Chief Operating Officer) Sale 10,514 11.84 124,517
2021-03-01 Campbell Bradley L (Chief Operating Officer) Option Ex 10,514 6.45 67,815
2021-03-01 Whitman Burke W (Director) Buy 1,500 12.40 18,600
2021-02-22 Crowley John F (Chairman & CEO) Sale 7,682 11.98 92,030
2021-02-16 Crowley John F (Chairman & CEO) Sale 22,000 12.26 269,698
2021-02-16 Crowley John F (Chairman & CEO) Option Ex 22,000 6.45 141,900
2021-02-01 Crowley John F (Chairman & CEO) Sale 7,500 19.08 143,077
2021-02-01 Campbell Bradley L (Chief Operating Officer) Sale 10,514 19.08 200,575
2021-02-01 Campbell Bradley L (Chief Operating Officer) Option Ex 10,514 6.45 67,815
2021-02-01 Whitman Burke W (Director) Buy 1,500 19.09 28,636
2021-01-20 Crowley John F (Chairman & CEO) Sale 50,000 21.51 1,075,350
2021-01-15 Crowley John F (Chairman & CEO) Sale 22,000 22.24 489,368
2021-01-15 Crowley John F (Chairman & CEO) Option Ex 22,000 6.45 141,900
2021-01-04 Crowley John F (Chairman & CEO) Sale 7,500 22.17 166,305
2021-01-04 Campbell Bradley L (Chief Operating Officer) Sale 10,514 22.17 233,126
2021-01-04 Campbell Bradley L (Chief Operating Officer) Option Ex 10,514 6.45 67,815
2021-01-04 Whitman Burke W (Director) Buy 1,500 23.17 34,755
2020-12-21 Quimi Daphne (Chief Financial Officer) Sale 5,000 24.09 120,475
2020-12-21 Quimi Daphne (Chief Financial Officer) Option Ex 5,000 2.94 14,700
2020-12-15 Quimi Daphne (Chief Financial Officer) Option Ex 30,321 3.33 100,817
2020-12-15 Crowley John F (Chairman & CEO) Sale 22,000 23.91 526,108
2020-12-15 Crowley John F (Chairman & CEO) Option Ex 22,000 6.45 141,900
2020-12-15 Campbell Bradley L (Chief Operating Officer) Option Ex 20,828 5.42 112,783
2020-12-14 Do Hung (Chief Science Officer) Sale 111,125 23.88 2,653,331
2020-12-01 Crowley John F (Chairman & CEO) Sale 7,500 22.77 170,775
2020-12-01 Campbell Bradley L (Chief Operating Officer) Sale 24,783 22.77 564,184
2020-12-01 Campbell Bradley L (Chief Operating Officer) Option Ex 24,783 2.52 62,453
2020-12-01 Whitman Burke W (Director) Buy 1,500 23.50 35,250
2020-11-04 Prout Samantha (Principal Accounting Officer) Sale 5,931 20.00 118,620
2020-11-04 Prout Samantha (Principal Accounting Officer) Option Ex 5,931 12.46 73,900
2020-11-02 Crowley John F (Chairman & CEO) Sale 33,875 17.87 605,278
2020-11-02 Crowley John F (Chairman & CEO) Option Ex 23,975 5.96 142,891
2020-11-02 Campbell Bradley L (Chief Operating Officer) Sale 24,782 17.87 442,804
2020-11-02 Campbell Bradley L (Chief Operating Officer) Option Ex 24,782 2.52 62,450
2020-11-02 Whitman Burke W (Director) Buy 1,500 18.01 27,015
2020-10-09 Do Hung (Chief Science Officer) Sale 193,700 15.03 2,911,311
2020-10-09 Do Hung (Chief Science Officer) Option Ex 193,700 9.97 1,931,770
2020-10-02 Quimi Daphne (Chief Financial Officer) Option Ex 11,000 2.45 26,950
2020-10-01 Quimi Daphne (Chief Financial Officer) Sale 5,000 14.02 70,100
2020-10-01 Quimi Daphne (Chief Financial Officer) Option Ex 5,000 2.94 14,700
2020-10-01 Crowley John F (Chairman & CEO) Sale 29,900 14.02 419,108
2020-10-01 Crowley John F (Chairman & CEO) Option Ex 20,000 5.96 119,200
2020-10-01 Whitman Burke W (Director) Buy 1,500 14.28 21,412
2020-09-30 Barth Jay (Chief Medical Officer) Sale 4,064 14.51 58,952
2020-09-30 Barth Jay (Chief Medical Officer) Option Ex 4,064 2.29 9,306
2020-09-28 Campbell Bradley L (Chief Operating Officer) Sale 24,782 13.89 344,197
2020-09-28 Campbell Bradley L (Chief Operating Officer) Option Ex 24,782 2.52 62,450
2020-09-01 Crowley John F (Chairman & CEO) Sale 29,900 14.18 423,862
2020-09-01 Crowley John F (Chairman & CEO) Option Ex 20,000 5.96 119,200
2020-09-01 Whitman Burke W (Director) Buy 1,500 14.62 21,930
2020-08-31 Barth Jay (Chief Medical Officer) Sale 28,750 14.74 423,746
2020-08-31 Barth Jay (Chief Medical Officer) Option Ex 28,750 6.10 175,375
2020-08-17 Crowley John F (Chairman & CEO) Sale 20,000 14.89 297,820
2020-08-17 Crowley John F (Chairman & CEO) Option Ex 20,000 5.13 102,600
2020-08-05 Prout Samantha (Principal Accounting Officer) Sale 198 15.05 2,979
2020-08-05 Prout Samantha (Principal Accounting Officer) Option Ex 198 10.04 1,987
2020-08-03 Crowley John F (Chairman & CEO) Sale 39,655 14.78 586,100
2020-08-03 Crowley John F (Chairman & CEO) Option Ex 20,000 5.96 119,200
2020-08-03 Campbell Bradley L (Chief Operating Officer) Sale 10,000 14.78 147,780
2020-08-03 Campbell Bradley L (Chief Operating Officer) Option Ex 10,000 6.06 60,599
2020-08-03 Whitman Burke W (Director) Buy 1,500 14.53 21,795
2020-07-27 Barth Jay (Chief Medical Officer) Sale 30,000 15.05 451,380
2020-07-27 Barth Jay (Chief Medical Officer) Option Ex 30,000 6.10 183,000
2020-07-16 Rosenberg Ellen (Chief Legal Officer) Sale 30,000 15.26 457,920
2020-07-16 Rosenberg Ellen (Chief Legal Officer) Option Ex 30,000 5.16 154,800
2020-07-15 Crowley John F (Chairman & CEO) Sale 20,000 15.54 310,840
 1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of FOLD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Amicus Therapeutics, Inc. (symbol FOLD, CIK number 1178879) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.